Recently, a new class action lawsuit accuses RoC Opco LLC of misleading consumers by claiming its Retinol Correxion Deep Wrinkle Serum Cleanser provides the anti-aging benefits of retinol. Filed on Feb. 19 in a California federal court, the lawsuit alleges that the cleanser is ineffective because it is rinsed off too quickly for the retinol to take effect.
The plaintiffs argue that retinol, a vitamin A derivative, must undergo a biological conversion into its active form, retinoic acid, which requires consistent, long-term skin exposure. Because RoC’s cleanser is a rinse-off product, the lawsuit claims it cannot deliver the advertised wrinkle-reducing benefits. The complaint alleges that RoC exploits consumer trust in retinol without educating them on how it works.
The plaintiffs seek to represent all U.S. consumers who purchased the product, with specific representation for buyers in 15 states, including California, Florida, and New York. They are suing for violations of consumer protection laws and unjust enrichment, demanding damages, restitution, and injunctive relief.
This lawsuit echoes a 2022 case against L’Oréal USA, which faced similar allegations over misleading collagen claims in its anti-aging products.
It is reported that in January 2024, Bridgepoint Europe VII acquired RoC Skincare. According to previous reports, Bridgepoint Europe VII stated that RoC’s revenue has grown by 70% since 2020. The facial skincare market within the dermocosmetics sector in the U.S. and Europe is expected to continue outpacing the broader skincare category, a trend reflected in products targeting aging skin.
